Preferred Label : Myosin Phosphatase Pathway;
NCIt synonyms : Myosin Pathway;
NCIt related terms : PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase;
Alternative definition : BIOCARTA: The phosphorylation of myosin affects its role in smooth muscle contraction,
platelet formation, and possibly other processes. Phosphorylation by myosin light
chain kinase (MLCK) increases myosin activity and dephosphorylation by myosin phosphatase
decreases myosin activity. CPI, a factor that binds to and inhibits myosin phosphatase,
is a target of phosphorylation by PKC and PKN. The inhibitory activity of CPI is regulated
by its own phosphorylation state; when CPI is phosphorylated, its inhibitory activity
is increased. The activation of signal transduction cascades such as GPCR pathways
can lead to activation of PKC, phosphorylation of CPI, inhibition of myosin phosphatase,
increased myosin phosphorylation, and increased smooth muscle contraction or platelet
release. The action of histamine in vasoconstriction, for example, may be mediated
by activation of PKC through the histamine receptor, resulting in phosphorylation
of CPI-17, increased inhibition of myosin phosphatase, and increased smooth muscle
contraction. (This definition may be outdated - see the DesignNote.);
NCIt note : The BIOCARTA Definition (ALT_DEFINITION) for this pathway concept was provided by
BioCarta. This property was not created by, nor is it maintained by the NCI Thesaurus
staff. Additionally, BioCarta is no longer updating its pathway data; thus, the BIOCARTA
Definition might be outdated or inaccurate. Please see the Terms and Conditions for
Use at http://www.biocarta.com/.;
Biocarta ID : h_myosinPathway;
Origin ID : C39160;
UMLS CUI : C1513801;
- Semantic type(s)
- has_gene_product_element
- pathway_has_gene_element